Clinical trials for new drug products may offer hope for patients with rare conditions. Physicians and patients may seek to be a part of a clinical trial. However, prior to 2010, compensation offered to participants in a clinical trial impacted eligibility for the Medicaid program. A measure offered this month by the leadership of the Senate Finance Committee (S 139, plus HR 209) seeks to continue allowing Medicaid patients access to drug trials. The legislation extends beyond this year the income exclusion for people who participate in rare disease clinical trials.
Full story
댓글 없음:
댓글 쓰기